Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Core Insights - Profusa, Inc. has announced a collaboration with Prof. Dr. Marianne Brodmann from the Medical University of Graz, Austria, to adopt the Lumee oxygen platform technology in her practice, which involves approximately 1,500 annual vascular procedures [1][2] - Prof. Brodmann, as the principal investigator of clinical studies that supported Lumee oxygen's CE marking, will integrate Profusa's platform technology into clinical study programs [1][2] - The collaboration aims to validate the Lumee technology platform and expand its market reach through integration into clinical practices [3] Company Overview - Profusa is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors that provide continuous, actionable medical-grade data [4] - The company aims to offer long-lasting, injectable, and affordable biosensors, creating a personalized biochemical signature for reliable clinical use [4]